Using mobile health technology for breast cancer diagnosis in Nigeria
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria
This study tests whether training Nigerian radiologists to use mobile health devices for breast biopsies can improve breast cancer diagnosis and patient care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 900 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 8 sites (New York, New York and 7 other locations) |
| Trial ID | NCT05561842 on ClinicalTrials.gov |
What this trial studies
This study aims to train Nigerian radiologists in performing ultrasound-guided breast biopsies using mobile health devices. By implementing a practical training program, the researchers seek to enhance the skills of local healthcare providers in diagnosing breast cancer. The focus is on creating a sustainable model that integrates technology into clinical practice, thereby improving patient outcomes in low and middle-income countries. The study will involve the use of mHealth devices to facilitate this training and implementation.
Who should consider this trial
Good fit: Ideal candidates for this study are females aged 18 and older with a suspicious solid mass detected on breast ultrasound.
Not a fit: Patients who are under 18 years old or unwilling to provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve breast cancer diagnosis and treatment accessibility for women in Nigeria.
How similar studies have performed: Other studies have shown success in using mobile health technologies for medical training and diagnostics, indicating a promising approach in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 and older female. * Breast ultrasound demonstrating a solid mass that is suspicious for cancer, which would typically undergo either a blind biopsy or surgical excision at the Nigerian hospital where the patient is seeking diagnosis. Exclusion Criteria: * Participants unwilling to sign consent. * Participants under the age of 18.
Where this trial is running
New York, New York and 7 other locations
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York, United States (Recruiting)
- Lagos University Teaching Hospital — Idi Araba, Lagos, Nigeria (Recruiting)
- Olabisis Onabanjo University Teaching Hospital (Data Collection Only) — Sagamu, Ogun State, Nigeria (Active_not_recruiting)
- Federal Medical Centre Owo (Data Collection Only) — Owo, Ondo State, Nigeria (Recruiting)
- University College Hospital (Data Collection Only) — Ibadan, Oyo State, Nigeria (Active_not_recruiting)
- University Of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla Enugu — Enugu, Nigeria (Recruiting)
- Obafemi Awolowo University Teaching Hospitals Complex (Data Collection Only) — Ile-Ife, Nigeria (Recruiting)
- University of Ilorin Teaching Hospitals — Ilorin, Nigeria (Active_not_recruiting)
Study contacts
- Principal investigator: Eliabeth Sutton, MD — Memorial Sloan Kettering Cancer Center
- Study coordinator: Elizabeth Sutton, MD
- Email: suttone@mskcc.org
- Phone: 646-888-5455
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.